Boditech Media
-
PRESS RELEASE
Boditech Med Signs MOU with China’s Autobio for Joint Development and Sales Collaboration
Comprehensive partnership established to jointly develop core products and expand sales.
-
PRESS RELEASE
Boditech Med Completes CE-IVDR Certification for 14 Diagnostic Devices and 142 Diagnostic Kits
Products verified to meet increasingly stringent global certification standards
-
PRESS RELEASE
Boditech Med Reports Record Sales of 28.08 million USD in Q3 2024, Highest Since COVID-19 Endemic
Consolidated revenue for Q3 2024 recorded at 28.08 million USD (37.6 billion KRW), with an operating profit of 6.57 million USD (8.8 billion KRW).
-
PRESS RELEASE
Boditech Med Reports Operating Profit of 7.15 Million USD in Q2 2024, Up 13% Year-on-Year
Sales reached 27.85 million USD (36.2 billion KRW) with an operating profit of 7.15 million USD (9.3 billion KRW) in Q2 2024
-
PRESS RELEASE
Boditech Med Signs MOU with Taiwan's BPM for Diabetic Kidney Disease Prediction Marker
MOU signed for the license of diabetic kidney disease prediction marker 'DNlite-IVD103'.
-
PRESS RELEASE
Boditech Med, Q1 2024 Sales Reach $21.6 Million (33.1 Billion Won) ... Up 12.3% YoY
Consolidated sales for Q1 2024 amounted to $21.6 million (33.1 billion won), with operating profit recorded at $4.2 million (5.9 billion won).
-
PRESS RELEASE
Boditech Med Acquires 3.03% Stake in 4TEEN4, a German Developer of Products for Cardiogenic Shock
Planned launch of DPP3 on-site diagnostic products, capable of predicting myocardial infarction shock progression, expected within this year
-
NEWS
Performance Validation of Boditech Med's AFIAS D-dimer in Thrombosis Research Journal
Superiority Demonstrated in Capillary Whole Blood and Venous Plasma Correlation Analysis
-
PRESS RELEASE
Boditech Med, Obtains Export Permit for the Biomarker 'PenKid' for Acute Kidney Injury Diagnosis
Obtained an Export Permit for PenKid, which enables a rapid diagnosis of acute kidney injury within 15 minutes
-
PRESS RELEASE
Boditech Med Obtains Emergency Use Authorization (EUA) for COVID-19 Home Test Kit from US FDA
Through its U.S. subsidiary, Immunostics, Boditech Med obtains emergency use authorization for COVID-19 home test kits.